CIK: 0001615982 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $2,024,518 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HELP | CYBIN INC | 3,840,250 | $31,413 | 1.6% | $6.44 | 0.0% | COM NEW | 23256X407 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SYRE | SPYRE THERAPEUTICS INC | 3,685,448 (+37.2%) | $120,735 (+168.3%) | 6.0% | $19.91 | +31.2% | COM NEW | 00773J202 |
| SVRA | SAVARA INC | 13,740,375 (+8.4%) | $82,854 (+83.0%) | 4.1% | $2.96 | +65.3% | COM | 805111101 |
| MAZE | MAZE THERAPEUTICS INC | 1,548,569 (+25.8%) | $64,157 (+101.0%) | 3.2% | $20.47 | +67.9% | COM | 578784100 |
| CBIO | CRESCENT BIOPHARMA INC. | 2,133,576 (+53.7%) | $25,304 (+53.3%) | 1.2% | $18.21 | -30.0% | COM | G2545C104 |
| ZURA | ZURA BIO LTD | 5,345,115 (+15.4%) | $28,008 (+39.7%) | 1.4% | $2.77 | +42.9% | CLASS A ORD SHS | G9TY5A101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,000,000 (+4.1%) | $41,210 (+9.0%) | 2.0% | $18.52 | +109.3% | COM | 252828108 |
| VOR | VOR BIOPHARMA INC | 1,943,766 (+288.8%) | $25,424 (+4.4%) | 1.3% | $24.17 | -23.0% | COM NEW | 929033207 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | METSERA INC | 3,750,662 | $196,272 | 9.7% | $27.22 | — | — | 59267L107 |
| — | CIDARA THERAPEUTICS INC | 946,788 | $90,664 | 4.5% | $48.29 | — | — | 171757206 |
| ABVX | ABIVAX SA | 576,729 | $48,964 | 2.4% | $11.63 | — | — | 00370M103 |
| — | ASTRIA THERAPEUTICS INC | 2,457,348 | $17,889 | 0.9% | $8.36 | — | — | 04635X102 |
| PHVS | PHARVARIS N V | 674,599 | $16,831 | 0.8% | $15.96 | +50.9% | — | N69605108 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 750,000 | $7,950 | 0.4% | $10.07 | +11.9% | — | G70077105 |
| TENX | TENAX THERAPEUTICS INC | 437,708 | $3,331 | 0.2% | $5.55 | +56.8% | — | 88032L605 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX INC | 7,315,547 (-44.4%) | $88,811 (-42.3%) | 4.4% | $4.80 | +153.1% | COM | 67576A100 |
| ORIC | ORIC PHARMACEUTICALS INC | 5,676,230 (-14.0%) | $46,432 (-41.3%) | 2.3% | $7.60 | +51.4% | COM | 68622P109 |
| COGT | COGENT BIOSCIENCES INC | 2,000,000 (-50.0%) | $71,040 (+23.7%) | 3.5% | $8.47 | +232.1% | COM | 19240Q201 |
| ENGN | ENGENE HOLDINGS INC | 4,771,414 (-5.4%) | $43,086 (+25.0%) | 2.1% | $10.25 | -21.8% | COM | 29286M105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 8,493,321 | $641,076 | 31.7% | $22.03 | +185.9% | COM | 03770N101 |
| ORKA | ORUKA THERAPEUTICS INC | 4,148,428 | $125,739 | 6.2% | $29.65 | -6.0% | COM | 687604108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 3,882,709 | $120,830 | 6.0% | $19.32 | +42.0% | COM | 92790C104 |
| ERAS | ERASCA INC | 17,857,083 | $66,428 | 3.3% | $2.08 | +35.1% | COM | 29479A108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 6,728,985 | $108,673 | 5.4% | $8.91 | +48.7% | COM | 483497103 |
| JBIO | JADE BIOSCIENCES INC | 3,220,364 | $49,690 | 2.5% | $33.31 | -64.8% | COM NEW | 008064206 |
| CTMX | CYTOMX THERAPEUTICS INC | 15,561,500 | $66,292 | 3.3% | $1.68 | +126.5% | COM | 23284F105 |
| ELVN | ENLIVEN THERAPEUTICS INC | 3,226,331 | $49,685 | 2.5% | $18.38 | +8.4% | COM | 29337E102 |
| DYN | DYNE THERAPEUTICS INC | 2,173,913 | $42,522 | 2.1% | $11.80 | +60.5% | COM | 26818M108 |
| UPB | UPSTREAM BIO INC | 1,169,298 | $31,746 | 1.6% | $22.33 | +11.5% | COM | 91678A107 |
| SRZN | SURROZEN INC | 632,931 | $14,304 | 0.7% | $11.62 | +39.2% | COM NEW | 86889P208 |
| CGEM | CULLINAN THERAPEUTICS INC | 1,379,965 | $14,283 | 0.7% | $21.29 | -57.6% | COM | 230031106 |
| SEPN | SEPTERNA INC | 610,808 | $17,029 | 0.8% | $8.80 | +171.5% | COM | 81734D104 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 1,609,569 | $6,905 | 0.3% | $11.59 | -67.4% | COM | 04317A107 |
| CASI | CASI PHARMACEUTICALS INC | 987,259 | $839 | 0.0% | $6.09 | -78.8% | ORD SHS | G1933S101 |